Enhancement of alpha interferon activity against HCV replication in the HCV replicon cell culture model using combination therapy.

被引：0
|
作者：
Korba, B [1 ]
Ciancio, A [1 ]
Rinaudo, J [1 ]
Korba, B [1 ]
Ciancio, A [1 ]
Rinaudo, J [1 ]
机构：
[1] Georgetown Univ, Med Ctr, Rockville, MD USA
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
486
引用
收藏
页码：284A / 284A
页数：1
相关论文
共 50 条
  • [31] Combination therapy with interferon alpha and ribavirin for hepatitis C virus (HCV) infection in multiply transfused thalassaemic patients.
    Telfer, PT
    Whitby, K
    Grant, P
    Garson, JA
    Hoffbrand, AV
    Wonke, B
    BLOOD, 1996, 88 (10) : 2096 - 2096
  • [32] Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy
    Okuse, C
    Rinaudo, JA
    Farrar, K
    Wells, F
    Korba, BE
    ANTIVIRAL RESEARCH, 2005, 65 (01) : 23 - 34
  • [33] Influence of Th1 and Th2 cytokines on response of HCV infection to combined Alpha Interferon-Ribavirin therapy.
    Lebelt, A
    Leevy, CB
    Rabara, HP
    Zierer, K
    Zweil, P
    HEPATOLOGY, 1998, 28 (04) : 569A - 569A
  • [34] Intracellular expression of recombinant human immunoglobulin (IGGI) against NS3 inhibits helicase activity and HCV replication in cell culture.
    Khalap, N
    Burioni, R
    Clementie, M
    Dash, S
    HEPATOLOGY, 2001, 34 (04) : 350A - 350A
  • [35] Predicting response to initial therapy with interferon alfa during ribavirin in chronic hepatitis C using serum HCV RNA during therapy.
    McHutchison, JG
    Gordon, SC
    Morgan, T
    Ling, MH
    Gaurad, JJ
    Albrecht, J
    Dienstag, J
    HEPATOLOGY, 1999, 30 (04) : 365A - 365A
  • [36] Inhibition of replication of an HCV-poliovirus chimera in cell culture using a novel ribozyme motif:: The Zinzyme™.
    Macejak, DG
    Jensen, KL
    Zinnen, SP
    Mokler, V
    Pavco, PA
    Blatt, LM
    HEPATOLOGY, 2001, 34 (04) : 490A - 490A
  • [37] LONGITUDINAL-STUDY OF ANTIBODIES AGAINST THYROID IN PATIENTS UNDERGOING INTERFERON-ALPHA THERAPY FOR HCV CHRONIC HEPATITIS
    CARELLA, C
    AMATO, G
    BIONDI, B
    ROTONDI, M
    MORISCO, F
    TUCCILLO, C
    CHIUCHIOLO, N
    SIGNORIELLO, G
    CAPORASO, N
    LOMBARDI, G
    HORMONE RESEARCH, 1995, 44 (03) : 110 - 114
  • [38] Extra-corporeal photopheresis (ECP) alone and in combination with interferon-alpha (IFNV-alpha) for treatment of patients with chronic hepatitis C (HCV) who have previously failed IFN-alpha therapy.
    OBrien, CB
    Henzel, B
    Stouch, B
    Moonka, D
    HEPATOLOGY, 1996, 24 (04) : 603 - 603
  • [39] SPONTANEOUS INVITRO SECRETION OF ANTI-HCV CORRELATES WITH DISEASE-ACTIVITY AND RESPONSE TO THERAPY WITH INTERFERON-ALPHA
    LOHR, HF
    MEYER, KH
    NAGEL, C
    DIENES, HP
    MICHEL, G
    GERKEN, G
    GASTROENTEROLOGY, 1993, 104 (04) : A944 - A944
  • [40] Clearance and rebound kinetics of HCV RNA in replicon cells treated with VX-950, a novel HCVNS34A protease inhibitor, alone or in combination with interferon alpha
    Lin, K
    Perni, RB
    Kwong, AD
    Lin, C
    JOURNAL OF HEPATOLOGY, 2004, 40 : 11 - 11
12345